Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


Immunology (Collaborator)

Tumour Microenvironment (Collaborator)

Translational Research (Collaborator)

Alistair Easton

BSc, MBChB, PhD, FRCPath

Senior Clinical Researcher


Investigating the effects of conventional chemo-radiotherapy on the immune infiltrate in neuroblastoma and the biology of cancer-associated gangliosides relating to their role in tumourogenesis and as a target for immunotherapy


Alistair studied Medicine at The University of Glasgow and completed an intercalated BSc in Immunology during his undergraduate studies. He trained as a clinical pathologist in the West of Scotland Training School, based at the Western Infirmary, the Royal Infirmary and the Queen Elizabeth University Hospitals in Glasgow. During this training he was awarded a Pathological Society Centenary Clinical Fellowship to complete a PhD in autoimmunity and pathogen ganglioside mimicry in Guillain Barre Syndrome, supervised by Prof Hugh Willison, Dr Carl Goodyear and Prof Allan Mowat, at The University of Glasgow.

In 2014, following completion of his specialist training, he was appointed as Associate Professor and Honorary Consultant at the University of Southampton, where his research interests included tumour immunology, tumour glycosylation and neuroblastoma.  In 2019 he was appointed to his current post as a Senior Clinical Researcher at the Department of Oncology.